Dr. Lal PathLabs approved the grant of 75,000 stock options to employees and allotted 93,900 equity shares, raising paid-up equity share capital to INR 83,57,42,520; Ved Prakash Goel is re-designated as Group CFO and CEO - International Business.
AI Assistant
Dr Lal Pathlabs Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.